Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07058207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Weight Management in Obese Cancer Patients During Curative Active Treatment

Study acronym: CANOBESE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 28, 2025 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2025 to Jul 22, 2025
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain. The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.
Trial Details
NCT Number NCT07058207
Lead Sponsor Institut d'Investigació Biomèdica de Bellvitge
Collaborators: World Cancer Research Fund International, Institut Català d'Oncologia
Conditions
(from sponsor)		 Obesity, Solid Neoplasm, Stage II-IV, Curative Treatment
Related terms Motor Activity, Neoplasms, Obesity, Patient Compliance, Patient Dropouts, Weight Loss
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov